{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T19:51:25Z","timestamp":1775245885867,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T00:00:00Z","timestamp":1538956800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Histochem Cell Biol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s00418-018-1739-9","type":"journal-article","created":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T04:55:50Z","timestamp":1538974550000},"page":"305-313","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Versican silencing in BeWo cells and its implication in gestational trophoblastic diseases"],"prefix":"10.1007","volume":"151","author":[{"given":"Keyla S. N.","family":"Pires","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue Y.","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla M.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaqueline C.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liliane P. G.","family":"Tenorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayane M.","family":"Botelho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Lucia M.","family":"Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hillary Gabriela S.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen Priscila T.","family":"Pendeloski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Daher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen S. C.","family":"Borbely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre U.","family":"Borbely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,8]]},"reference":[{"key":"1739_CR1","first-page":"241","volume":"59","author":"A Braga","year":"2014","unstructured":"Braga A, Uberti EMH, Fajardo MC, Viggiano M, Sun SY, Grillo BM, Padilha SL, Andrade JM, Souza CB, Madi JM, Maest\u00e1 I, Silveira E (2014) Epidemiological report on the treatment of patients with gestational trophoblastic disease in 10 Brazilian referral centers. Results after 12 years since international FIGO 200 consensus. J Reprod Med 59:241\u2013247","journal-title":"J Reprod Med"},{"key":"1739_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ajog.2016.04.010","volume":"215","author":"A Braga","year":"2016","unstructured":"Braga A, Maest\u00e1 I, Rocha Soares R, Elias KM, Cust\u00f3dio Domingues MA, Barbisan LF, Berkowitz RS (2016) Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia. Am J Obstet Gynecol 215:336.e1-336.e12","journal-title":"Am J Obstet Gynecol"},{"key":"1739_CR3","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/labinvest.2015.152","volume":"96","author":"TN Bukong","year":"2016","unstructured":"Bukong TN, Maurice SB, Chahal B, Schaeffer DF, Winwood PJ (2016) Versican: a novel modulator of hepatic fibrosis. Lab Invest 96:361\u2013374","journal-title":"Lab Invest"},{"key":"1739_CR4","doi-asserted-by":"publisher","first-page":"e0133056","DOI":"10.1371\/journal.pone.0133056","volume":"10","author":"JM Carthy","year":"2015","unstructured":"Carthy JM, Meredith AJ, Boroomand S, Abraham T, Luo Z, Knight D, McManus BM (2015) Versican V1 overexpression induces a myofibroblast-like phenotype in cultured fibroblasts. PLoS One 10:e0133056","journal-title":"PLoS One"},{"key":"1739_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/BF00198951","volume":"181","author":"M Castellucci","year":"1990","unstructured":"Castellucci M, Scheper M, Scheffen I, Celona A, Kaufmann P (1990) The development of the human placental villous tree. Anat Embryol 181:117\u2013128","journal-title":"Anat Embryol"},{"key":"1739_CR6","doi-asserted-by":"publisher","first-page":"47626","DOI":"10.1074\/jbc.M206521200","volume":"277","author":"S Cattaruzza","year":"2002","unstructured":"Cattaruzza S, Schiappacassi M, Ljungberg-Rose A, Spessotto P, Perissinotto D, M\u00f6rgelin M, Mucignat MT, Colombatti A, Perris R (2002) Distribution of PG-M\/versican variants in human tissues and de novo expression of isoform V3 upon endothelial cell activation, migration and neoangiogenesis in vitro. J Biol Chem 277:47626\u201347635","journal-title":"J Biol Chem"},{"key":"1739_CR7","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1053\/plac.1998.0375","volume":"20","author":"CC Chan","year":"1999","unstructured":"Chan CC, Lao TT, Cheung AN (1999) Apoptotic and proliferative activities in first trimester placentae. Placenta 20:223\u2013227","journal-title":"Placenta"},{"key":"1739_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/rheumatology\/keh222","volume":"43","author":"AN Corps","year":"2014","unstructured":"Corps AN, Robinson AH, Movin T, Costa ML, Ireland DC, Hazleman BL, Riley GP (2014) Versican splice variant messenger RNA expression in normal human Achilles tendon and tendinopathies. Rheumatology 43:969\u2013972","journal-title":"Rheumatology"},{"key":"1739_CR9","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1369\/jhc.3A6176.2004","volume":"52","author":"IP Crocker","year":"2004","unstructured":"Crocker IP, Tansinda DM, Jones CJ, Baker PN (2004) The influence of oxygen and tumor necrosis factor-alpha on the cellular kinetics of term placental villous explants in culture. J Histochem Cytochem 52:749\u2013757","journal-title":"J Histochem Cytochem"},{"issue":"1","key":"1739_CR10","doi-asserted-by":"publisher","first-page":"12.8.112.8.24","DOI":"10.1002\/0471141755.ph1208s56","volume":"56","author":"BS Cummings","year":"2012","unstructured":"Cummings BS, Wills LP, Schnellmann RG (2012) Measurement of cell death in Mammalian cells. Curr Protoc Pharmacol 56(1):12.8.1\u201312.8.24","journal-title":"Curr Protoc Pharmacol"},{"key":"1739_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1186\/1757-2215-7-70","volume":"7","author":"M Desjardins","year":"2014","unstructured":"Desjardins M, Xie J, Gurler H, Muralidhar GG, Sacks JD, Burdette JE, Barbolina MW (2014) Versican regulates metastasis of epithelial ovarian carcinoma cells and spheroids. J Ovarian Res 7:67\u201370","journal-title":"J Ovarian Res"},{"key":"1739_CR12","first-page":"701","volume":"28","author":"WW Du","year":"2013","unstructured":"Du WW, Yang W, Yee AJ (2013) Roles of versican in cancer biology- tumorigenesis, progression and metastasis. Histol Histopathol 28:701\u2013713","journal-title":"Histol Histopathol"},{"key":"1739_CR13","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1016\/j.addr.2007.08.008","volume":"59","author":"SP Evanko","year":"2007","unstructured":"Evanko SP, Tammi MI, Tammi RH, Wight TN (2007) Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev 59:1351\u20131365","journal-title":"Adv Drug Deliv Rev"},{"key":"1739_CR14","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1096\/fj.12-220905","volume":"7","author":"L Fang","year":"2013","unstructured":"Fang L, Du WW, Yang X, Chen K, Ghanekar A, Levy G, Yang W, Yee AJ, Lu WY, Xuan JW, Gao Z, Xie F, He C, Deng Z, Yang BB (2013) Versican 3\u2032-untranslated region (3\u2032-UTR) functions as a ceRNA in inducing the development of hepatocellular carcinoma by regulating miRNA activity. FASEB J 7:907\u2013919","journal-title":"FASEB J"},{"key":"1739_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1146\/annurev-pathol-052016-100237","volume":"12","author":"P Hui","year":"2017","unstructured":"Hui P, Buza N, Murphy KM, Ronnett BM (2017) Hydatidiform moles: genetic basis and precision diagnosis. Ann Rev Pathol Mech Dis 12:449\u2013485","journal-title":"Ann Rev Pathol Mech Dis"},{"key":"1739_CR16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1017\/S0965539502000220","volume":"13","author":"B Huppertz","year":"2003","unstructured":"Huppertz B, Kaufmann P, Kingdom J (2003a) Trophoblast turnover in health and disease. Fetal Maternal Med Rev 13:103\u2013118","journal-title":"Fetal Maternal Med Rev"},{"key":"1739_CR17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1053\/plac.2002.0903","volume":"24","author":"B Huppertz","year":"2003","unstructured":"Huppertz B, Kingdom J, Caniggia I, Desoye G, Black S, Korr H, Kaufmann P (2003b) Hypoxia favours necrotic versus apoptotic shedding of placental syncytiotrophoblast into the maternal circulation. Placenta 24:181\u2013190","journal-title":"Placenta"},{"key":"1739_CR18","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/00004347-199601000-00006","volume":"15","author":"MD Jeffers","year":"1996","unstructured":"Jeffers MD, Richmond JA, Smith R (1996) Trophoblast proliferation rate does not predict progression to persistent gestational trophoblastic disease in complete hydatidiform mole. Int J Gynecol Pathol 15:34\u201338","journal-title":"Int J Gynecol Pathol"},{"key":"1739_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1097\/00004347-200207000-00008","volume":"21","author":"HD Kato","year":"2002","unstructured":"Kato HD, Terao Y, Ogawa M, Matsuda T, Arima T, Kato K, Yong Z, Wake N (2002) Growth-associated gene expression profiles by microarray analysis of trophoblast of molar pregnancies and normal villi. Int J Gynecol Pathol 21:255\u2013260","journal-title":"Int J Gynecol Pathol"},{"key":"1739_CR20","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/ijc.24812","volume":"126","author":"P Kischel","year":"2010","unstructured":"Kischel P, Walttregny D, Dumont B, Turtoi A, Greffe Y, Kirsch S, De Pauw E, Castronovo E (2010) Versican overexpression in human breast cancer lesions: known and new isoforms for stromal tumor targeting. Int J Cancer 126:640\u2013650","journal-title":"Int J Cancer"},{"key":"1739_CR21","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1002\/jcp.10043","volume":"190","author":"JM Lemire","year":"2002","unstructured":"Lemire JM, Merrilees MJ, Braun KR, Wight TN (2002) Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration and proliferation in vitro. J Cell Physiol 190:38\u201345","journal-title":"J Cell Physiol"},{"key":"1739_CR22","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1159\/000369660","volume":"34","author":"F Li","year":"2014","unstructured":"Li F, Li S, Cheng T (2014) TGF-beta1 promotes osteosarcoma cell migration and invasion through the miR-143-versican pathway. Cell Physiol Biochem 34:2169\u20132179","journal-title":"Cell Physiol Biochem"},{"key":"1739_CR23","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ajog.2010.06.072","volume":"204","author":"JR Lurain","year":"2011","unstructured":"Lurain JR (2011) Gestational trophoblastic disease II: classification and management of gestational trophoblastic neoplasia. Am J Obstet Gynecol 204:11\u201318","journal-title":"Am J Obstet Gynecol"},{"key":"1739_CR24","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1158\/1541-7786.MCR-16-0444","volume":"15","author":"Y Mitsui","year":"2015","unstructured":"Mitsui Y, Shiina H, Kato T, Maekawa S, Hashimoto Y, Shiina M, Imai-Sumida M, Kulkarni P, Dasgupta P, Wong RK, Hiraki M, Arichi N, Fukuhara S, Yamamura S, Majid S, Saini S, Deng G, Dahiya R, Nakajima K, Tanaka Y (2015) Versican promotes tumor progression, metastasis and predicts poor prognosis in renal carcinoma. Mol Cancer Res 15:884\u2013895","journal-title":"Mol Cancer Res"},{"key":"1739_CR25","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.ijgo.2015.06.008","volume":"131","author":"HY Ngan","year":"2015","unstructured":"Ngan HY, Seckl MJ, Berkowitz RS, Xiang Y, Golfier F, Sekharan PK, Lurain JR (2015) Update on the diagnosis and management of gestational trophoblastic disease. Int J Gynaecol Obstet 131:S123\u2013S126","journal-title":"Int J Gynaecol Obstet"},{"key":"1739_CR26","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3892\/or.2014.3252","volume":"32","author":"G Oktem","year":"2014","unstructured":"Oktem G, Sercan O, Guven U, Uslu R, Uysal A, Goksel G, Ayla S, Bilir A (2014) Cancer stem cell differentiation: TGFbeta1 and versican may trigger molecules for the organization of tumor spheroids. Oncol Rep 32:641\u2013649","journal-title":"Oncol Rep"},{"key":"1739_CR27","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1242\/jcs.113.5.807","volume":"113","author":"M Schmalfeldt","year":"2010","unstructured":"Schmalfeldt M, Bandtlow CE, Dours-Zimmermann MT, Winterhalter KH, Zimmermann DR (2010) Brain derived versican V2 is a potent inhibitor of axonal growth. J Cell Sci 113:807\u2013816","journal-title":"J Cell Sci"},{"key":"1739_CR28","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/annonc\/mdt345","volume":"24","author":"MJ Seckl","year":"2013","unstructured":"Seckl MJ, Sebire NJ, Fisher RA, Golfier F, Massuger L, Sessa C, ESMO Guidelines Working Group (2013) Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 24:39\u201350","journal-title":"Ann Oncol"},{"key":"1739_CR29","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1091\/mbc.e04-04-0295","volume":"16","author":"W Sheng","year":"2005","unstructured":"Sheng W, Wang G, Wang Y, Liang J, Wen J, Zheng PC, Wu Y, Lee Y, Slingerland J, Dumont D, Yang BB (2005) The roles of versican V1 and V2 isoforms in cell proliferation and apoptosis. Mol Biol Cell 16:1330\u20131340","journal-title":"Mol Biol Cell"},{"key":"1739_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.ygyno.2015.05.002","volume":"138","author":"SY Sun","year":"2015","unstructured":"Sun SY, Melamed A, Goldstein DP, Bernstein MR, Horowitz NS, Moron AF, Maest\u00e1 I, Braga A, Berkowitz RS (2015) Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia? Gynecol Oncol 138:46\u201349","journal-title":"Gynecol Oncol"},{"key":"1739_CR31","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1590\/SO100-720320150005366","volume":"37","author":"EMH Uberti","year":"2015","unstructured":"Uberti EMH, Fajardo MC, Cunha AGV, Frota SS, Braga A, Ayub ACK (2015) Treatment of low-risk gestational trophoblastic neoplasia comparing biweekly eight-day methotrexate with folinic acid versus bolus-dose actinomycin-D, among Brazilian women. Rev Bras Ginecol Obstet 37:258\u2013265","journal-title":"Rev Bras Ginecol Obstet"},{"key":"1739_CR32","doi-asserted-by":"publisher","first-page":"e76122","DOI":"10.1371\/journal.pone.0076122","volume":"8","author":"J Werfel","year":"2013","unstructured":"Werfel J, Krause S, Bischof AG, Mannix RJ, Tobin H, Bar-Yam Y, Bellin RM, Ingber DE (2013) How changes in extracellular matrix mechanics and gene expression variability might combine to drive cancer progression. PLoS One 8:e76122","journal-title":"PLoS One"},{"key":"1739_CR33","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/0014-4827(90)90310-7","volume":"186","author":"B Wice","year":"1990","unstructured":"Wice B, Menton D, Geuze H, Schwartz AL (1990) Modulators of cyclic AMP metabolism induce syncytiotrophoblast formation in vitro. Exp Cell Res 186:306\u2013316","journal-title":"Exp Cell Res"},{"key":"1739_CR34","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1016\/j.bbagen.2013.12.028","volume":"1840","author":"TN Wight","year":"2014","unstructured":"Wight TN, Kinsella MG, Evanko SP, Potter-Perigo S, Merrilees J (2014) Versican and the regulation of cell phenotype in disease. Biochem Biophys Acta 1840:2441\u20132451","journal-title":"Biochem Biophys Acta"},{"key":"1739_CR35","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/01.AOG.0000174583.51617.25","volume":"106","author":"AJ Wolfberg","year":"2005","unstructured":"Wolfberg AJ, Berkowitz RS, Goldstein DP, Feltmate C, Lieberman E (2005) Postevacuation hCG levels and risk of gestational trophoblastic neoplasia in women with complete molar pregnancy. Obstet Gynecol 106:548\u2013552","journal-title":"Obstet Gynecol"},{"key":"1739_CR36","doi-asserted-by":"publisher","first-page":"12294","DOI":"10.1074\/jbc.M110748200","volume":"277","author":"Y Wu","year":"2002","unstructured":"Wu Y, Chen L, Zheng PS, Yang BB (2002) Beta 1-integrin-mediated glioma cell adhesion and free radical-induced apoptosis are regulated by binding to a C-terminal domain of PG-M\/versican. J Biol Chem 277:12294\u201312301","journal-title":"J Biol Chem"},{"key":"1739_CR37","doi-asserted-by":"publisher","first-page":"2093","DOI":"10.1091\/mbc.e03-09-0667","volume":"15","author":"Y Wu","year":"2004","unstructured":"Wu Y, Sheng W, Chen L, Dong H, Lee V, Lu F, Wong CS, Lu WY, Yang BB (2004) Versican V1 isoform induces neuronal differentiation and promotes neurite outgrowth. Mol Biol Cell 15:2093\u20132104","journal-title":"Mol Biol Cell"}],"container-title":["Histochemistry and Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-018-1739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00418-018-1739-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00418-018-1739-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T18:53:29Z","timestamp":1775242409000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00418-018-1739-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,8]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["1739"],"URL":"https:\/\/doi.org\/10.1007\/s00418-018-1739-9","relation":{},"ISSN":["0948-6143","1432-119X"],"issn-type":[{"value":"0948-6143","type":"print"},{"value":"1432-119X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,8]]},"assertion":[{"value":"4 October 2018","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2018","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Use of tissues was approved by the ethical committees from all involved institutions through the Brazilian unified system for human ethical committees, the <i>Plataforma Brasil<\/i> (protocol number: 43605515.9.0000.5013), requiring patients informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The datasets used and\/or analyzed during the current study are available from the corresponding author on reasonable request.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data availability"}}]}}